Clin Mol Hepatol.  2023 Apr;29(2):342-344. 10.3350/cmh.2023.0106.

Management of hepatocellular carcinoma in China: Seeking common grounds while reserving differences

Affiliations
  • 1Department of Hepatobiliary Surgery, Eastern Hepatobiliary Surgery Hospital, Second Military Medical University (Naval Medical University), Shanghai, China

Keyword

Hepatocellular carcinoma; China; Hepatectomy; Molecular targeted therapy; Immunotherapy
Full Text Links
  • CMH
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr